BCL2L1 and neoplasm: Comparing the four canonical MB subgroups in detail, Group 3 tumours both expressed BCL2L1 (BCL-XL) and BBC3 at significantly higher levels than the other subgroups and showed significantly lower BCL2L12 expression than the MBSHH and MBWNT subgroups (Fig. 6c).